Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma

The phosphoinositide 3-kinase (PI3K) signaling pathway is the most commonly mutated pathway in head and neck squamous cell carcinoma (HNSCC). There are several drugs targeting members of the PI3K signaling pathway in development for HNSCC. In this article, we review the genetic alterations reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yi, Dodhia, Sonam, Su, Gloria H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400658/
https://www.ncbi.nlm.nih.gov/pubmed/28108737
http://dx.doi.org/10.18632/oncotarget.14729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400658/
https://www.ncbi.nlm.nih.gov/pubmed/28108737
http://dx.doi.org/10.18632/oncotarget.14729

Ejemplares similares